IMEIK(300896)2025-05-05 15:35Investment Rating - The report maintains an "Outperform" rating for the company [1][2][16]. Core Views - The company experienced a revenue decline of 17.9% year-on-year in Q1 2025 due to a high base effect, with revenue reported at RMB 660 million. However, there was a slight quarter-on-quarter growth of 1.5% compared to Q4 2024 [3][11]. - The gross margin remained stable at 93.9%, while operating expenses increased due to higher sales, administrative, and R&D expense ratios [12]. - Non-recurring gains offset the revenue decline, leading to a net profit of RMB 440 million, down 15.9% year-on-year, with a net profit margin of 66.9% [13]. - The company is planning to acquire 85% of South Korean company REGEN, which is expected to significantly contribute to revenue and profits starting in 2026 [14][16]. - Revenue and net profit forecasts for 2025 and 2026 are projected at RMB 3.30 billion and RMB 3.60 billion, and RMB 2.02 billion and RMB 2.18 billion respectively, indicating year-on-year growth of 9.2% and 9.1% for revenue, and 3.1% and 7.7% for net profit [15][16]. Financial Summary - For 2025, the company is expected to achieve revenue of RMB 3.30 billion and net profit of RMB 2.02 billion, with respective growth rates of 9.2% and 3.1% [15]. - The projected diluted EPS for 2025 is RMB 6.67, with a P/E ratio of 26 [5][9]. - The company maintains a strong gross profit margin of 94.6% for 2025, with a projected return on equity (ROE) of 20.6% [5][9].